Research Papers:
An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 3065 views | HTML 3707 views | ?
Abstract
Shuyao Tang1, Gang Tan2, Xian Jiang1, Peng Han1, Bo Zhai2, Xuesong Dong1, Haiquan Qiao1, Hongchi Jiang1, Xueying Sun1
1The Hepatosplenic Surgery Center, Department of General Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin, China
2Department of General Surgery, the Fourth Affiliated Hospital of Harbin Medical University, Harbin, China
Correspondence to:
Xueying Sun, email: [email protected], [email protected]
Keywords: sorafenib, hepatocellular carcinoma, drug resistance, LncRNA, miRNA
Received: June 13, 2016 Accepted: September 21, 2016 Published: September 28, 2016
ABSTRACT
Sorafenib resistance remains a major obstacle for the effective treatment of hepatocellular carcinoma (HCC), and a number of miRNAs contribute to this resistance. However, the regulatory networks of miRNAs are very complex, thus inhibiting a single miRNA may sequentially activate other compensatory pathways. In the present study, we generated an artificial long non-coding RNA (AlncRNA), which simultaneously targets multiple miRNAs including miR-21, miR-153, miR-216a, miR-217, miR-494 and miR-10a-5p. These miRNAs have been shown to be upregulated in sorafenib-resistant cells and participate in the mechanisms underlying sorafenib resistance. The AlncRNA contains tandem sequences of 6 copies of the complementary binding sequences to the target miRNAs and is expressed by an adenoviral vector (Ad5-AlncRNA). Infection of Ad5-AlncRNA into sorafenib-resistant HCC cells blocked the function of miRNAs, and sequentially inhibited the downregulation of PTEN and activation of AKT. Ad5-AlncRNA significantly inhibited proliferation and induced apoptosis of sorafenib-resistant cells and enhanced the effects of sorafenib in vitro and in animal models. Inhibition of autophagy decreased the sensitivity of sorafenib-resistant cells to Ad5-AlncRNA, while its induction had the opposite effect. These results indicate that targeting multiple miRNAs by the artificial lncRNA could be a potential promising strategy for overcoming sorafenib resistance in the treatment of HCC.
![Creative Commons License](/images/80x15.png)
PII: 12304